Exacerbation of Chronic Obstructive Pulmonary Disease

被引：0
作者：
Xianghui Zhou
Qingling Li
Xincan Zhou
机构：
[1] The First Xuzhou People’s Hospital,Department of Respiratory Medicine
来源：
Cell Biochemistry and Biophysics | 2015年 / 73卷
关键词：
COPD; Exacerbation; Virus; Bacteria; Innate immunity; Inflammation; Review;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Chronic obstructive pulmonary disease (COPD) is a disease with high prevalence and substantial associated economical burden. A significant determinant of quality of life, long-term survival, and health care costs is an acute exacerbation of COPD. Acute exacerbations are provoked by respiratory viruses, altered airway microbiome, and environmental factors. The current treatment options are limited. In order to develop specific therapeutic measures, it is important to understand how acute exacerbations evolve. This review focuses on pathophysiology of stable and exacerbated COPD.
引用
收藏
页码：349 / 355
页数：6
相关论文
共 50 条
[41]   Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease [J].
Christine R. Jenkins ;
Dirkje S. Postma ;
Antonio R. Anzueto ;
Barry J. Make ;
Stefan Peterson ;
Göran Eriksson ;
Peter M. Calverley .
BMC Pulmonary Medicine, 15
[42]   The Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease and Exacerbation Definition: A Review [J].
Toy, Edmond L. ;
Gallagher, Kevin F. ;
Stanley, Elizabeth L. ;
Swensen, Andrine R. ;
Duh, Mei Sheng .
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2010, 7 (03) :214-228
[43]   BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease [J].
Yifei Duan ;
Siyi Zhou ;
Jianmiao Wang .
Respiratory Research, 24
[44]   Management of Chronic Obstructive Pulmonary Disease Patients after Hospitalization for Acute Exacerbation [J].
Osthoff, Mirjam ;
Leuppi, Joerg D. .
RESPIRATION, 2010, 79 (03) :255-261
[45]   Leptin as a local inflammatory marker in chronic obstructive pulmonary disease acute exacerbation [J].
Masoud, Hossam H. ;
Abd El-Hafeez, Ahmed M. ;
Ismail, Mohamed S. ;
Baharetha, Naef G. .
EGYPTIAN JOURNAL OF BRONCHOLOGY, 2019, 13 (02) :139-147
[46]   Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation -: EFRAM Study [J].
Garcia-Aymerich, J ;
Monsó, E ;
Marrades, RM ;
Escarrabill, J ;
Félez, MA ;
Sunyer, J ;
Antó, JM ;
Alonso, J ;
Barreiro, E ;
Farrero, E ;
Redondo, MJ ;
Soler, N ;
Torres, A ;
Bonet, G ;
Izquierdo, J ;
Morera, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (06) :1002-1007
[47]   Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease [J].
Jo, Yong Suk ;
Kim, Kyung Joo ;
Rhee, Chin Kook ;
Ha Yoo, Kwang ;
Jung, Ki-Suck ;
Park, Yong-Bum .
RESPIRATORY RESEARCH, 2022, 23 (01)
[48]   Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease [J].
Jenkins, Christine R. ;
Postma, Dirkje S. ;
Anzueto, Antonio R. ;
Make, Barry J. ;
Peterson, Stefan ;
Eriksson, Goran ;
Calverley, Peter M. .
BMC PULMONARY MEDICINE, 2015, 15
[49]   Clinical predictors of exacerbation frequency in chronic obstructive pulmonary disease [J].
Brusse-Keizer, Marjolein ;
van der Palen, Job ;
van der Valk, Paul ;
Hendrix, Ron ;
Kerstjens, Huib .
CLINICAL RESPIRATORY JOURNAL, 2011, 5 (04) :227-234
[50]   Optimum treatment for chronic obstructive pulmonary disease exacerbation prevention [J].
Karur, Pradeep ;
Singh, Dave .
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (24)
12345